These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings. Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS. Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407 [TBL] [Abstract][Full Text] [Related]
4. [Prevalence of antibodies against HTLV-III in various regions in Switzerland]. Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208 [TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. Feorino PM; Jaffe HW; Palmer E; Peterman TA; Francis DP; Kalyanaraman VS; Weinstein RA; Stoneburner RL; Alexander WJ; Raevsky C N Engl J Med; 1985 May; 312(20):1293-6. PubMed ID: 2985992 [TBL] [Abstract][Full Text] [Related]
6. Virologic studies in a case of transfusion-associated AIDS. Groopman JE; Salahuddin SZ; Sarngadharan MG; Mullins JI; Sullivan JL; Mulder C; O'Hara CJ; Cheeseman SH; Haverkos H; Forgacs P N Engl J Med; 1984 Nov; 311(22):1419-22. PubMed ID: 6092957 [TBL] [Abstract][Full Text] [Related]
7. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Sarngadharan MG; diMarzo Veronese F; Lee S; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106 [TBL] [Abstract][Full Text] [Related]
8. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome. Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany. Erfle V; Hehlmann R; Mellert W; Krüger G; Seifried E; Heimpel H; Rasokat H; Lechler E; Holzer E; Hellstern P Cancer Res; 1985 Sep; 45(9 Suppl):4627s-4629s. PubMed ID: 3860292 [TBL] [Abstract][Full Text] [Related]
10. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592 [TBL] [Abstract][Full Text] [Related]
11. Screening for AIDS. Med Lett Drugs Ther; 1985 Mar; 27(684):29-30. PubMed ID: 2984526 [TBL] [Abstract][Full Text] [Related]
12. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [TBL] [Abstract][Full Text] [Related]
13. HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis. Madden DL; Tzan NR; Roman GC; Detels R; Mundon FK; Fuccillo DA; Sever JL Yale J Biol Med; 1987; 60(6):569-74. PubMed ID: 2893497 [TBL] [Abstract][Full Text] [Related]
14. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy]. Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134 [TBL] [Abstract][Full Text] [Related]
15. Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk. Markham PD; Salahuddin SZ; Popovic M; Patel A; Veren K; Fladager A; Orndorff S; Gallo RC Cancer Res; 1985 Sep; 45(9 Suppl):4588s-4591s. PubMed ID: 2990690 [TBL] [Abstract][Full Text] [Related]
16. HTLV-III AIDS link. Bennett JA Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353 [TBL] [Abstract][Full Text] [Related]
17. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan. Ikegami N AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640 [TBL] [Abstract][Full Text] [Related]
19. Immune functions in homosexual men with antibodies to HTLV-III in Finland. Krohn K; Ranki A; Antonen J; Valle SL; Suni J; Vaheri A; Saxinger C; Gallo RC Clin Exp Immunol; 1985 Apr; 60(1):17-24. PubMed ID: 2988832 [TBL] [Abstract][Full Text] [Related]